A genetic variation in microRNA target site of ETS2 is associated with clinical outcomes of paclitaxel-cisplatin chemotherapy in non-small cell lung cancer (Q27853343)
Jump to navigation
Jump to search
scientific article
- A genetic variation in microRNA target site of <i>ETS2</i> is associated with clinical outcomes of paclitaxel-cisplatin chemotherapy in non-small cell lung cancer
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A genetic variation in microRNA target site of ETS2 is associated with clinical outcomes of paclitaxel-cisplatin chemotherapy in non-small cell lung cancer |
scientific article |
|
Statements
1 reference
A genetic variation in microRNA target site of ETS2 is associated with clinical outcomes of paclitaxel-cisplatin chemotherapy in non-small cell lung cancer (English)
1 reference
29 March 2016
0 references
7
0 references
13
0 references
15948-58
0 references
1 reference
1 reference